Close Menu
Shares of Cepheid rose 12.3 percent for the five-day trading week ended Tuesday. Last week, the firm said that it had received European clearance and began marketing its Xpert MRSA/SA-Blood Cultures and Xpert MRSA/SA-Skin and Soft Tissue Infection SSTI molecular diagnostic tests.
 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.